Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNMT3A | Q9Y6K1 | 1/20 | 0.60 |
| ▸ | GAA | P10253 | 1/20 | 0.59 |
| ▸ | CA1 | P00915 | 3/20 | 0.59 |
| ▸ | CA2 | P00918 | 3/20 | 0.59 |
| ▸ | CA9 | Q16790 | 2/20 | 0.59 |
| ▸ | CA12 | O43570 | 1/20 | 0.59 |
| ▸ | CA7 | P43166 | 1/20 | 0.58 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.58 |
| ▸ | NAMPT | P43490 | 2/20 | 0.57 |
| ▸ | LMNA | P02545 | 2/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
| ▸ | SYK | P43405 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29561675 | 0.85 | ALOX5 (0.58) | DNMT3ASYK | |
| SCHEMBL898238 | 0.85 | ALOX5 (0.58) | DNMT3ASYK | |
| SCHEMBL5071230 | 0.85 | THRA (0.57) | DNMT3AGAALMNAALDH1A1SYK | |
| SCHEMBL4488518 | 0.83 | GAA (0.79) | GAACA1CA2CA9CA12 | |
| SCHEMBL15329262 | 0.81 | ESRRG (0.60) | LMNACYP1A2CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL6267575 | 0.81 | CYP1A2 (0.65) | GAACA1CA2CA9CA12 | |
| SCHEMBL23351382 | 0.80 | GAA (0.69) | GAACA1CA2CA9CA12 | |
| SCHEMBL1812144 | 0.79 | MEN1 (0.65) | GAACA1CA2CA9CA12 | |
| SCHEMBL9809660 | 0.78 | OPRM1 (0.54) | NAMPTLMNAALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL28475160 | 0.78 | NAMPT (0.63) | GAACA1CA2CA9CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10730886-B2 | Compound having effect of inhibiting platelet aggregation and salt thereof, and composition for preventing or treating thrombotic diseases, containing same | SHIN POONG PHARMACEUTICAL CO., LTD. (KR) | 2020-08-04 | — | — | US | claimed |
| US-20180251472-A1 | Compound Having Effect Of Inhibiting Platelet Aggregation And Salt Thereof, And Composition For Preventing Or Treating Thrombotic Diseases, Containing Same | SHIN POONG PHARMACEUTICAL CO., LTD. (KR) | 2018-09-06 | — | — | US | claimed |
| EP-3345910-A1 | COMPOUND HAVING EFFECT OF INHIBITING PLATELET AGGREGATION AND SALT THEREOF, AND COMPOSITION FOR PREVENTING OR TREATING THROMBOTIC DISEASES, CONTAINING SAME | Shin Poong Pharmaceutical Co., Ltd. (KR) | 2018-07-11 | — | — | EP | claimed |
| EP-3345910-B1 | COMPOUND HAVING EFFECT OF INHIBITING PLATELET AGGREGATION AND SALT THEREOF, AND COMPOSITION FOR PREVENTING OR TREATING THROMBOTIC DISEASES, CONTAINING SAME | SHIN POONG PHARMACEUTICAL CO LTD (KR) | 2023-11-01 | — | — | EP | disclosed |
| EP-3345910-B1 | COMPOUND HAVING EFFECT OF INHIBITING PLATELET AGGREGATION AND SALT THEREOF, AND COMPOSITION FOR PREVENTING OR TREATING THROMBOTIC DISEASES, CONTAINING SAME | SHIN POONG PHARMACEUTICAL CO LTD (KR) | 2023-11-01 | — | — | EP | disclosed |
| CN-108602837-B | Compound having platelet aggregation inhibitory effect, salt thereof, and composition for preventing or treating thrombotic diseases comprising same | 新丰制药株式会社 | 2022-02-11 | — | — | CN | disclosed |
| US-10730886-B2 | Compound having effect of inhibiting platelet aggregation and salt thereof, and composition for preventing or treating thrombotic diseases, containing same | SHIN POONG PHARMACEUTICAL CO., LTD. (KR) | 2020-08-04 | — | — | US | disclosed |
| US-10730886-B2 | Compound having effect of inhibiting platelet aggregation and salt thereof, and composition for preventing or treating thrombotic diseases, containing same | SHIN POONG PHARMACEUTICAL CO., LTD. (KR) | 2020-08-04 | — | — | US | disclosed |
| US-20180251472-A1 | Compound Having Effect Of Inhibiting Platelet Aggregation And Salt Thereof, And Composition For Preventing Or Treating Thrombotic Diseases, Containing Same | SHIN POONG PHARMACEUTICAL CO., LTD. (KR) | 2018-09-06 | — | — | US | disclosed |
| EP-3345910-A1 | COMPOUND HAVING EFFECT OF INHIBITING PLATELET AGGREGATION AND SALT THEREOF, AND COMPOSITION FOR PREVENTING OR TREATING THROMBOTIC DISEASES, CONTAINING SAME | Shin Poong Pharmaceutical Co., Ltd. (KR) | 2018-07-11 | — | — | EP | disclosed |
| EP-3345910-A1 | COMPOUND HAVING EFFECT OF INHIBITING PLATELET AGGREGATION AND SALT THEREOF, AND COMPOSITION FOR PREVENTING OR TREATING THROMBOTIC DISEASES, CONTAINING SAME | Shin Poong Pharmaceutical Co., Ltd. (KR) | 2018-07-11 | — | — | EP | disclosed |
| WO-2017039395-A1 | COMPOUND HAVING EFFECT OF INHIBITING PLATELET AGGREGATION AND SALT THEREOF, AND COMPOSITION FOR PREVENTING OR TREATING THROMBOTIC DISEASES, CONTAINING SAME | 신풍제약 주식회사 | 2017-03-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180251472-A1 | Compound Having Effect Of Inhibiting Platelet Aggregation And Salt Thereof, And Composition For Preventing Or Treating Thrombotic Diseases, Containing Same | PLA2G7, JAK2, PF4 | DNMT3A 4535/4885GAA 2276/4885CA1 3819/4885 |
| US-10730886-B2 | Compound having effect of inhibiting platelet aggregation and salt thereof, and composition for preventing or treating thrombotic diseases, containing same | PLA2G7, JAK2, PF4 | DNMT3A 4535/4885GAA 2276/4885CA1 3819/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.